Navigation Links
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Date:9/9/2009

on 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements reflect Cumberland's current views with respect to future events, based on what it believes are reasonable assumptions. No assurance can be given, however, that these events will occur. As with any business, all phases of Cumberland's operations are subject to influences outside its control. Any one, or a combination, of these risk factors could materially affect the results of the Cumberland's operations. These factors include among other things, market conditions, the commercialization of Caldolor, Cumberland's dependence on Acetadote and Kristalose to generate almost all of its revenues, intense competition from existing and new products, which could diminish the commercial potential of Cumberland's products, an inability of manufacturers to produce Cumberland's products on a timely basis or a failure of manufacturers to comply with stringent regulations applicable to pharmaceutical drug manufacturers, maintaining and building an effective sales and marketing infrastructure, Cumberland's ability to identify and acquire rights to products, government regulation, the possibility that Cumberland's marketing exclusivity and patent rights may provide only limited protection from competition, and other factors discussed in our Registration Statement declared effective by the SEC on August 10, 2009. There can be no assurance that the results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequences to or effects on the Company or its business and operations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to ref
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Cumberland Pharmaceuticals Announces Appointments
3. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
4. Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
5. Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... is the event of the year for the latest ... of the Acute Cardiovascular Care Association (ACCA) of the ... October in Geneva, Switzerland. , Monday 16 September ... the specialty of cardiology dealing with acute problems in ... and acute heart failure. The scientific programme is available ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 According ... Market Research "Latin America Home Healthcare Market (By ... Healthcare Devices, Mobility Assist Devices and Medical Supplies; ... Infusion Therapy and Unskilled Home Healthcare Services) - ... 2014 - 2020" the Latin American Home Healthcare ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 Norfolk, ... of delectable gluten-free and allergy friendly desserts, announced today ... for Breast Cancer Awareness Month this October. In support ... eliminating cancer, Lucy’s® will provide a charitable donation in ... one of the most common cancers among women in ...
(Date:9/16/2014)... HealthDay Reporter , MONDAY, Sept. 15, ... face a higher risk of developing an aggressive type of ... suggests. But, the study authors noted that it,s not ... should be concerned. Their study only found an association between ... prove cause and effect. "It is conceivable that, in ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Current students ... the Capstone Event in Yelm, Washington, Oct. 20-26 to ... the year and caps off the remarkable “Masters of ... world in Switzerland, Italy, Australia, South Korea, Mexico, and ... half price for children ages 6-19 and for seniors ...
Breaking Medicine News(10 mins):Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 2Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 2Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 3Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 2Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 3Health News:Ramtha School Presents Capstone Event in Yelm Oct. 20-26 2
... extensively drug-resistant tuberculosis (XDR TB) in the United States, ... and difficult-to-treat disease between 1993 and 2006, and 77 ... The study appears in the August 15 issue of ... California reports almost 3,000 cases of tuberculosis annually, the ...
... benefits are weighed , , WEDNESDAY, Aug. 13 (HealthDay ... suggests. , Would-be participants in an extramarital affair tend ... researchers from the University of New Hampshire (UNH) and ... the decision differ slightly between men and women, said ...
... Network Growing, BUFFALO, N.Y., Aug. 13 ... national, electronic healthcare network,and has announced the ... healthcare providers., (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NYW083LOGO ... Medina Memorial Health Care,System, and MedFirst Urgent ...
... and Two Rivers among Thomson ... MILWAUKEE, Aug. 13 Three Aurora Health Care facilities,are ... having,demonstrated the fastest, most consistent improvement over five consecutive,years., ... Medical Center of,Green Bay were ranked in the Thomson ...
... a,lazy Sunday with a great meal and relaxing spa treatments. Voda ... Sunday, from 12pm - 4pm, Voda Spa offers the taste and ... Brunch Massage $140 Brunch Scrub ... Choose from a selection of delicious dishes from our restaurant. All,brunches ...
... LAKE OSWEGO, Ore., Aug. 13 West Coast ... of LifeWorks Northwest, a,leading non-profit, community-based mental health ... pledge and a corporate gift. The donation,will sponsor ... Children and Youth Recreation Fund., Additionally, West ...
Cached Medicine News:Health News:Extensively drug-resistant tuberculosis found in California 2Health News:Men and Women Calculate Cost of Affairs 2Health News:Wolfson's HealthTransaction Network(R) Signs Four New Hospital Systems 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 3Health News:West Coast Bank Sponsors LifeWorks Northwest Programs for Children in Low-Income Housing Communities 2
(Date:9/15/2014)... Sept. 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers ... key market data on the Spain Aesthetic Lasers ... in millions of US dollars, volume (in units) ... segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) ... (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power ...
(Date:9/15/2014)... Sept. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem all ... its 6.75% Senior Notes due 2017, CUSIP Nos. 91911XAL8, ... and has mailed an irrevocable notice of redemption for ... copy of the irrevocable notice of redemption with respect ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne Medical Response, ... services, has been selected by Inc. Magazine as ... America. Photo - http://photos.prnewswire.com/prnh/20140914/145997 ... list identifies successful, privately-held companies with the largest ... Response, one of only two ambulance companies to ...
Breaking Medicine Technology:Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: